Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
DCPH | A | Deciphera Pharmaceuticals, Inc. | 0.02 | |
LDOS | A | Leidos Holdings, Inc. | 0.72 | |
FUSN | A | Fusion Pharmaceuticals Inc. | 0.09 | |
NBIX | B | Neurocrine Biosciences, Inc. | -0.37 | |
MACK | B | Merrimack Pharmaceuticals, Inc. | 0.20 | |
NKTR | B | Nektar Therapeutics | -3.33 | |
SRPT | B | Sarepta Therapeutics, Inc. | -0.74 | |
DCTH | B | Delcath Systems, Inc. | 0.35 | |
VNDA | B | Vanda Pharmaceuticals Inc. | 11.16 | |
CRVO | B | CervoMed Inc. | 0.00 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IBRN | D | iShares Neuroscience and Healthcare ETF | 10.03 | |
PINK | D | Simplify Health Care ETF | 8.61 | |
BBP | C | BioShares Biotechnology Products Fund | 8.18 | |
IDNA | C | iShares Genomics Immunology and Healthcare ETF | 7.13 | |
BBH | C | Market Vectors Biotech ETF | 5.33 |
Compare ETFs
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles